Total revenues * 3,695.63 4,387.88 (692.25) (15.8) 8,202.41 8,402.21 (199.80) (2.4) Total cost and expenses * 3,163.18 2,211.89 951.29 43.0 5,686.11 4,522.99 1,163.12 25.7 EBITDA 1,926.64 3,043.75

production process. 2. The company and its subsidiaries had cost of sales and services in the 2nd quarter of 2020 totaling of Baht 162.87 million or 68.33 percent of its revenue from sales and services. The

general patient decreased. However Social security revenue of subsidiaries increased due to the increase of the basic capitation payment rate in year 2020. 2. Cost of hospital operations & Administrative

revenues 38 109 (71) (65%) Cost of sale - - - - Other expenses (694) (493) 201 41% Total expenses (694) (493) 201 41% Operating profit (loss) (656) (384) (272) (71%) - EGCO Plus : The operating result was

/FY2020 Q3/FY2019 change %YoY Total Revenues 739.20 1,317.88 (578.68) -43.91% Cost of Sales and Services 679.59 1,206.22 (526.63) -43.66% Selling and Administrative Expenses 87.34 114.92 (27.58) -24.00

increased. 2. Cost of hospital operations & Administrative expenses increased by Baht 199.42 million or 9.04 % due to the increasing of medical personal expenses and the depreciation because of the expanding

%, decreased by 2.80% as a result of the higher cost while the price is not increased from the Covid-19 outbreak. The decrease in sales and gross profit margin in 1 and 2 make a decrease of 351.81 million baht

product management resulting in increased sales and reduced cost of sales Yours Sincerely, Mr. Perapol Suwannapasri Managing Director

last year by 18.02 million Baht or 16.53%. - Cost of sale and services, distribution costs and administrative expense were 91.70 million Baht decreased from the same period last year by 8.89 million Baht

year-over-year from Baht 188.13 million in 3Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including